TXG10x Genomics, Inc.
62.29USD+0.16%Mkt Cap: 8.10B $P/E:

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia P…

Key Statistics

Company
Market Cap8.10B $
Enterprise Value7.85B $
Revenue (TTM)616.91M $
Gross Profit443.88M $
Net Income (TTM)-43.54M $
Revenue/Share4.832 USD
Last Price62.29 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS88025U1097
Valuation
P/E (Trailing)
P/E (Forward)314.12
PEG
EV/EBITDA-190.49
EV/Revenue12.72
P/S13.49
P/B10.08
EPS (TTM)-0.61
EPS (Forward)0.20
52W Range
11.16100% of range62.36
52W High62.36 USD
52W Low11.16 USD
Profitability
Gross Margin69.05%
Oper. Margin-15.20%
EBITDA Margin-6.68%
Profit Margin-6.77%
ROE-5.47%
ROA-4.18%
Growth
Revenue Growth-12.70%
Earnings Growth
Cash Flow & Leverage
Operating CF136.05M $
CapEx (TTM)5.93M $
FCF Margin29.12%
FCF Yield2.22%
Net Debt-473.24M $
Net Debt/EBITDA11.49
Balance Sheet
Debt/Equity0.11
Current Ratio5.69
Quick Ratio5.08
Book Value/Sh6.337 USD
Cash/Share4.237 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)49.54 USD
Upside (mean)-20.5%
Target Range40.00 USD65.00 USD
$40.00-20.5% to mean$65.00
# Analysts13
Ownership
Shares Out.120.21M
Float118.18M
Insiders1.60%
Institutions112.02%
Short Interest
Short Ratio5.4d
Short % Float17.59%
Short % Out.11.99%
Shares Short15.63M
Short (prev mo.)16.34M
Technical
SMA 5044.05 (+41.4%)
SMA 20026.30 (+136.8%)
Beta2.04
S&P 52W Chg18.16%
Avg Vol (30d)3.03M
Avg Vol (10d)3.58M
Technical Indicators
RSI (14)74.4
MACD4.8463
MACD Signal4.1898
MACD Hist.+0.6565
BB Upper62.59 USD
BB Middle51.33 USD
BB Lower40.06 USD
BB Width43.89%
ATR (14)3.465 USD
Vol Ratio (20d)1.32x